The global bariatric surgery devices market is projected to reach USD 2.16 billion by 2023 from an estimated value of USD 1.64 billion in 2018, at a CAGR of 5.7%. Growth in the bariatric surgery devices market is mainly driven by the growing obese population, increasing number of bariatric surgeries performed, and increasing preference for minimally invasive surgical procedures.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=173150134

On the basis of type, the bariatric surgery devices market is broadly segmented into minimally invasive and non-invasive surgical devices. The minimally invasive surgical devices segment is further divided into stapling devices, energy/vessel-sealing devices, suturing devices, and accessories. The segment of minimally invasive surgical devices is estimated to account for the largest share of the bariatric surgery devices market in 2018 and is also expected to register the highest CAGR during the forecast period. The increasing prevalence of obesity worldwide, the demand for fewer incisions and scars, and the need for minimal discomfort and trauma are the factors driving the non-invasive weight loss surgical equipment market.

By procedure, the market has been segmented into sleeve gastrectomy, gastric bypass, revision surgery, adjustable gastric banding, non-invasive bariatric surgery, mini-gastric bypass, and biliopancreatic diversion with duodenal switch (BPD/DS). The sleeve gastrectomy segment accounted for the largest share of the market in 2017. This can be attributed to the advantages of sleeve gastrectomy—safety, effectiveness, and affordability and limited complications as compared to other bariatric procedures.

Asia Pacific is expected to register the highest CAGR during the forecast period. The high growth in this region can be attributed to the growing adolescent and adult population, increasing number of bariatric surgeries, rapidly rising co-morbidities such as diabetes, and government initiatives to curb obesity.

Increasing demand for affordable and easily accessible treatment options and emerging economies such as China, India, Brazil, Italy, and several Middle Eastern countries are expected to offer growth opportunities for players operating in the market. To leverage these opportunities, major players are focusing on enhancing their product portfolio and carrying out acquisitions, partnerships, and collaborations.